Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lymph node reticular cells and tissue macrophages represent a specialized cellular niche within the secondary lymphoid organs, serving as both a structural scaffold and an immunological filter (Fletcher et al., 2015). Fibroblastic reticular cells (FRCs) form a dense network that supports the lymph node architecture and facilitates the transport of small molecules through the conduit system (Girard et al., 2012). These cells also secrete essential chemokines like CCL19 and CCL21 to regulate the trafficking of T cells and dendritic cells. Tissue-resident macrophages, particularly those in the subcapsular and medullary sinuses, are responsible for capturing pathogens and antigens from the lymph, preventing systemic spread and initiating immune responses (Junt et al., 2008). While not a single molecular target, this cellular complex is a focal point for lymph-targeted drug delivery and diagnostic imaging agents. For instance, radiopharmaceuticals like Tilmanocept bind to mannose receptors (CD206) on these macrophages to identify sentinel lymph nodes in cancer staging (FDA, 2013). Understanding the interaction between these stromal and immune cells is vital for developing therapies that modulate lymphatic drainage and immune surveillance.
Binding to mannose receptors (CD206) on macrophages or phagocytic uptake by the reticuloendothelial system within the lymph node.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lymph node reticular cells and tissue macrophages.